Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by private equity firms
|
| gptkbp:awards |
Best Places to Work
Innovative Company Award |
| gptkbp:community_involvement |
Patient advocacy
Health education initiatives |
| gptkbp:customer_base |
Hospitals
Clinics Home healthcare providers |
| gptkbp:employees |
200+
|
| gptkbp:financial_products |
Revenue growth
Publicly traded |
| gptkbp:founded |
gptkb:2004
|
| gptkbp:founder |
gptkb:Danielle_D._Dyer
|
| gptkbp:future_plans |
gptkb:Global_expansion
Increase market presence Expand product line Partnerships with research institutions Enhance customer service Enhance research and development Invest in technology advancements Develop new treatment protocols Improve patient access to treatments Increase awareness of lymphedema |
| gptkbp:headquarters |
gptkb:Minneapolis,_Minnesota
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tactile Medical
|
| gptkbp:industry |
gptkb:hospital
|
| gptkbp:leadership |
gptkb:Film_Director
CEO is Dan Dyer |
| gptkbp:location |
gptkb:United_States
International markets |
| gptkbp:mission |
Improve the quality of life for patients with chronic conditions.
|
| gptkbp:partnerships |
Healthcare providers
Insurance companies |
| gptkbp:products |
Chronic venous insufficiency treatment devices
Lymphedema treatment devices |
| gptkbp:regulatory_compliance |
FDA approved
|
| gptkbp:research_focus |
Lymphedema
Chronic venous insufficiency |
| gptkbp:services |
Patient education
Clinical support |
| gptkbp:sustainability_initiatives |
Eco-friendly practices
Community health programs |
| gptkbp:symbol |
TCMD
|
| gptkbp:target_market |
Patients with chronic venous insufficiency
Patients with lymphedema |
| gptkbp:technology |
Compression therapy
Bioelectrical stimulation |
| gptkbp:website |
www.tactilemedical.com
|
| gptkbp:bfsParent |
gptkb:Teleflex
|
| gptkbp:bfsLayer |
5
|